Evolution of Workload Associated with Anti-VEGF Treatments for AMD, DME, RVO and mCNV in Hospital District of Southwest Finland.

Clinical ophthalmology (Auckland, N.Z.) Pub Date : 2024-12-08 eCollection Date: 2024-01-01 DOI:10.2147/OPTH.S479816
Hanna Heloterä, Anna-Mari Viita, Juha Laine
{"title":"Evolution of Workload Associated with Anti-VEGF Treatments for AMD, DME, RVO and mCNV in Hospital District of Southwest Finland.","authors":"Hanna Heloterä, Anna-Mari Viita, Juha Laine","doi":"10.2147/OPTH.S479816","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The prevalence of vision-threatening diseases, such as age-related macular degeneration (AMD) and diabetic macular edema (DME), is likely to increase in developed countries owing to an aging population, rising life expectancy, and unfavorable lifestyle changes. Increases in the burden of vision-threatening diseases pose a challenge to the healthcare system. After the emergence of intravitreal anti-VEGF inhibitors, treatment options for neovascular AMD (nAMD), DME, retinal vein occlusion (RVO) and myopic choroidal neovascularization (myopic CNV) have increased. As this change in treatment practices has occurred over the last two decades, it is important to demonstrate changes in patient numbers and administered treatments to provide solutions for handling the workload and productivity in ophthalmology departments. In addition, the registry data landscape has evolved in Finland in recent years. Thus, understanding the possibilities and limitations of ophthalmology registries and patient information systems is required.</p><p><strong>Methods: </strong>This study involved the secondary use of retrospectively registered data from the data warehouse of the Hospital District of Southwest Finland. Our goal was to explore how the workload of ophthalmology departments caused by intravitreal injections has evolved from 2015 to 2022.</p><p><strong>Results: </strong>The ophthalmology department workload increased significantly during our observation period as the total number of patients receiving intravitreal treatments for nAMD, DME, RVO, and myopic CNV increased 199.6% from 2015 to 2021. In addition, the total number of administered anti-VEGF injections increased during our observation period, but the increase rate began to subside (2019-2020: increase 23.7%, 2020-2021: increase 10.3%, 2021-2022: increase 6.7%).</p><p><strong>Conclusion: </strong>Supporting the utilization of registry data is essential in evidence-based discussions evolving workload in healthcare. However, it is important to understand the limitations and the quality of the registries. Our study contributes to better understanding the Finnish registry perspective, and it demonstrates the increase in workload in ophthalmology departments caused by intravitreal injections.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"18 ","pages":"3645-3655"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11640760/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical ophthalmology (Auckland, N.Z.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/OPTH.S479816","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The prevalence of vision-threatening diseases, such as age-related macular degeneration (AMD) and diabetic macular edema (DME), is likely to increase in developed countries owing to an aging population, rising life expectancy, and unfavorable lifestyle changes. Increases in the burden of vision-threatening diseases pose a challenge to the healthcare system. After the emergence of intravitreal anti-VEGF inhibitors, treatment options for neovascular AMD (nAMD), DME, retinal vein occlusion (RVO) and myopic choroidal neovascularization (myopic CNV) have increased. As this change in treatment practices has occurred over the last two decades, it is important to demonstrate changes in patient numbers and administered treatments to provide solutions for handling the workload and productivity in ophthalmology departments. In addition, the registry data landscape has evolved in Finland in recent years. Thus, understanding the possibilities and limitations of ophthalmology registries and patient information systems is required.

Methods: This study involved the secondary use of retrospectively registered data from the data warehouse of the Hospital District of Southwest Finland. Our goal was to explore how the workload of ophthalmology departments caused by intravitreal injections has evolved from 2015 to 2022.

Results: The ophthalmology department workload increased significantly during our observation period as the total number of patients receiving intravitreal treatments for nAMD, DME, RVO, and myopic CNV increased 199.6% from 2015 to 2021. In addition, the total number of administered anti-VEGF injections increased during our observation period, but the increase rate began to subside (2019-2020: increase 23.7%, 2020-2021: increase 10.3%, 2021-2022: increase 6.7%).

Conclusion: Supporting the utilization of registry data is essential in evidence-based discussions evolving workload in healthcare. However, it is important to understand the limitations and the quality of the registries. Our study contributes to better understanding the Finnish registry perspective, and it demonstrates the increase in workload in ophthalmology departments caused by intravitreal injections.

芬兰西南部地区医院抗血管内皮生长因子治疗老年性黄斑变性、老年性黑斑变性、老年性视网膜病变和间变性视网膜病变的工作量变化。
背景:由于人口老龄化、预期寿命延长以及不利的生活方式改变,威胁视力的疾病,如老年性黄斑变性(AMD)和糖尿病性黄斑水肿(DME),在发达国家的发病率可能会增加。危及视力疾病负担的增加给医疗保健系统带来了挑战。在玻璃体内抗血管内皮生长因子抑制剂出现后,治疗新生血管性黄斑变性(nAMD)、视网膜黄斑变性(DME)、视网膜静脉闭塞(RVO)和近视性脉络膜新生血管(近视性 CNV)的选择增加了。由于治疗方法在过去二十年中发生了变化,因此必须展示患者人数和治疗方法的变化,以便为处理眼科部门的工作量和生产率提供解决方案。此外,近年来芬兰的登记数据情况也发生了变化。因此,需要了解眼科登记和患者信息系统的可能性和局限性:本研究对芬兰西南部医院区数据仓库中的回顾性登记数据进行了二次利用。我们的目标是探索从2015年到2022年,眼科部门因玻璃体内注射而产生的工作量是如何变化的:结果:在我们的观察期内,眼科部门的工作量显著增加,因为从 2015 年到 2021 年,接受玻璃体内治疗的 nAMD、DME、RVO 和近视 CNV 患者总数增加了 199.6%。此外,在我们的观察期内,抗血管内皮生长因子注射的总次数也有所增加,但增幅开始减弱(2019-2020 年:增加 23.7%;2020-2021 年:增加 10.3%;2021-2022 年:增加 6.7%):支持利用登记册数据对于循证讨论医疗保健中不断变化的工作量至关重要。然而,了解登记册的局限性和质量也很重要。我们的研究有助于更好地理解芬兰登记处的观点,并证明了玻璃体内注射导致眼科工作量的增加。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.10
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信